E-Cadherin Gene Mutations Provide Clues to Diffuse Type Gastric Carcinomas

Cancer Research

Volumn 54, Issue 14, 1994, Pages 3845-3852

  Becker, Karl Friedrich ^a   Atkinson, Michael J ^a   Reich, Ulrike ^a   Becker, Ingrid ^b   Nekarda, Hjalmar ^b   Siewert, Jörg R ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; MESSENGER RNA; UVOMORULIN;

ALLELE; ARTICLE; CELL ADHESION; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE MUTATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PHENOTYPE; PRIORITY JOURNAL; RNA SPLICING; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CADHERINS; CHROMOSOME DELETION; HUMANS; LYMPHATIC METASTASIS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 0027977943     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Takeichi, M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science (Washington DC), 251: 1451-1455, 1991.
2. Frixen, U.H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Lochner, D., and Birchmeier, W. E-cadherin-raediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol., 113: 173-185, 1991.
3. Schipper, J.H., Frixen, U.H., Behrens, J., Unger, A., Jahnke, K., and Birchmeier, W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res., 51: 6328-6337, 1991.
4. Gamallo, C., Palacios, J., Suarez, A., Pizarro, A., Navarro, P., Quintanilla, M., and Cano, A. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinomas. Am. J. Pathol., 142: 987-993, 1993.
5. Umbas, R., Schalken, J.A., Aalders, T.W., Carter, B.S., Karthaus, K.F.M., Schaafsma, H.E., Debruyne, F.M.J., and Isaacs, W.B. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res., 52: 5104-5109, 1992.
6. Behrens, J., Vakaet, L., Friis, R., Winterhager, E., Van Roy, F., Mareel, M.M., and Birchmeier, W. Loss of epithelial differentiation and gain of invasivness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-src gene. J. Cell Biol., 120: 757-766, 1993.
7. Shimoyama, Y., and Hirohashi, S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res., 51: 2185-2192, 1991.
8. Oka, H., Shiozaki, H., Kobayashi, K., Tahara, H., Tamura, S., Miyata, M., Yuichirou, D., Iihara, K., Matsuyoshi, N., Hirano, S., Takeichi, M., and Mori, T. Immunohisto-chemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch. A Pathol. Anat., 421: 149-156, 1992.
9. Mayer, B., Johnson, J.P., Leitl, F., Jauch, K.W., Heiss, M.M., Schildberg, F.W., Birchmeier, W., and Funke, I. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferention and glandular disintegration. Cancer Res., 53: 1690-1695, 1993.
10. Becker, K.F., Atkinson, M.J., Reich, U., Huang, H.H., Nekarda, H., Siewert, J.R., and Hofler, H. Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum. Mol. Genet., 2: 803-804, 1993.
11. Laurdn, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type of carcinoma. Acta Pathol. Microbiol. Scand., 64: 31-49, 1965.
12. Sambrook, J., Fritsch, E.F., and Maniatis, T. Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
13. Klimpfinger, M., Zisser, G., Ruhri, C., Pütz, B., Steindorfer, P., and Hofler, H. Expression of c-myc and c-fos mRNA in colorectal carcinoma in man. Virchows Arch. B Cell Pathol., 59: 165-171, 1990.
14. Bussemakers, M.J.G., Bokhoven, A.v., Mees, S.G.M., Kemler, R., and Schalken, J.A. Molecular cloning and characterization of the human E-cadherin cDNA. Mol. Biol. Rep., 17: 123-128, 1993.
15. Marchuk, D., Drumm, M., Saulino, A., and Collins, F.S. Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res., 19: 1154, 1991.
16. Kovach, J.S., McGovern, R.M., Cassady, J.D., Swanson, S.K., Wold, L.E., Vogelstein, B., and Sommer, S.S. Direct sequencing from touch preparations of human carcinomas: analysis of p. 3 mutations in breast carcinomas. J. Natl. Cancer Inst., 83: 1004-1009, 1991.
17. Petty, E.M., Carstens, R., and Bale, A.E. Ornithine transcarbamylase polymorphism detected by PCR introduction of Dral site. Nucleic Acids Res., 19: 690, 1991.
18. Li, Y., Bollag, G., Clark, R., Stevens, J., Conroy, L., Fults, D., Ward, K., Friedman, E., Samowitz, W., Robertson, M., Bradley, P., McCormick, F., White, R., and Cawthon, R. Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell, 69: 275-281, 1992.
19. Ozawa, M., Hoschützky, H., Herrenknecht, K., and Kemler, R. A possible new adhesive site in the cell adhesion molecule uvomorulin. Mechanisms of Development. 33: 49-56, 1991.
20. Cordell, J.L., Falini, B., Erber, W.N., Ghosh, A.K., Abdulaziz, Z., MacDonald, S., Pulford, K.A.F., Stein, H., and Mason, D.Y. Immunoenzyme labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP-complexes). J. Histochem. Cytochem., 32: 219-229, 1984.
21. Ringwald, M., Schuh, R., Vestweber, D., Eistetter, H., Lottspeich, F., Engel, J., Dolz, R., Jähnig, F., Epplen, J., Mayer, S., Muller, C., and Kemler, R. The structure of the cell adhesion molecule uvomorulin. Insights into the molecular mechanism of Ca2+-dependent cell adhesion. EMBO J., 6: 3647-3653, 1987.
22. Ringwald, M., Baribault, H., Schmidt, C., and Kemler, R. The structure of the gene coding for the mouse cell adhesion molecule uvomorulin. Nucleic Acids Res., 19: 6533-6539, 1991.
23. Padgett, R.A., Grabowski, P.J., Konarska, M.M., Seiler, S., and Sharp, P.A. Splicing of messenger RNA precursors. Annu. Rev. Biochem., 55: 1119-1150, 1986.
24. Pagnini, C.A., and Rugge, M. Advanced gastric cancer and prognosis. Virchows Arch A Pathol. Anat., 406: 213-221, 1985.
25. Nevalainen, T.J., and Järvi, O.H. Ultrastructure of intestinal and diffuse type gastric carcinoma. J. Pathol., 122: 129-136, 1977.
26. Edelman, G.M., and Crossin, K.L. Cell adhesion molecules: implications for a molecular histology. Annu. Rev. Biochem., 60: 155-190, 1991.
27. Takeichi, M. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol., 5: 806-811, 1993.
28. Ozawa, M., Engel, J., and Kemler, R. Single amino acid substitution in one Ca2+ binding site of uvomorulin abolish the adhesive function. Cell, 63: 1033-1038, 1990.
29. Carothers, A.M., Urlaub, G., Mucha, J., Harvey, R.G., Chasin, L.A., and Grun-berger, D. Splicing mutations in the CHO DHFR gene preferentially induced by (+)-3a, 4βdihydroxy- la, 2a-epoxy-1, 2,3, 4-tetrahydrobenzo(c)phenanthrene. Proc. Nad. Acad. Sci. USA, 87: 5464-5468, 1990.
30. Kemler, R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet., 9: 317-321, 1993.
31. Shimoyama, Y., Nagafuchi, A., Fujita, S., Gotoh, M., Takeichi, M., Tsukita, S., and Hirohashi, S. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of a-catenin expression in reduced cell-cell adhesiveness. Cancer Res., 52; 5770-5774, 1992.
32. Morton, R.A., Ewing, C.M., Nagafuchi, A., Tsukita, S., and Isaacs, W.B. Reduction of E-cadherin levels and deletion of the a-catenin gene in human prostate cancer cells. Cancer Res., 53: 3585-3590, 1993.
33. Birchmeier, W., Weidner, K., Hülsken, J., and Behrens, J. Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. Semin. Cancer Biol., 4: 231-239, 1993.
34. Mareel, M.M., Vleminckx, K., Vermeulen, S., Bracke, M., and Van Roy, F. E-cadherin expression: a counterbalance for cancer cell invasion. Bull Cancer, 79: 347-355, 1992.
35. Natt, E., Magenis, R.E., Zimmer, J., Mansouri, A., and Scherer, G. Regional assignment of the human loci for uvomorulin (UVO) and chymotrypsinogen B (CTRB) with the help of two overlapping deletions of the long arm of chromosome 16. Cytogenet. Cell Genet., 30: 145-148, 1989.
36. Tsuda, H., Zhang, W., Shimosato, Y., Yokota, J., Terada, M., Sugimura, T., Miyamura, T., and Hirohashi, S. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 87: 6791-6794, 1990.
37. Carter, B.S., Ewing, C.M., Ward, W.S., Treiger, B.F., Aalders, T.W., Schalken, J.A., Epstein, J.I., and Isaacs, W.B. Allelic loss of chromosomes 16q and lOq in human prostate cancer. Proc. Natl. Acad. Sci. USA, 87: 8751-8755, 1990.
38. Sato, T., Tanigami, A., Yamakawa, K., Akiyama, F., Kasumi, F., Sakamoto, G., and Nakamura, Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res., 50: 7184-7189, 1990.
39. Maw, M.A., Grundy, P.E., Lynn, J.M., Eccles, M.R., Dunn, R.S., Smith, P.J., Feinberg, A.P., Law, D.J., Paterson, M.C., Telzerow, P.E., Callen, D.F., Thompson, A.D., Richards, R.I., and Reeve, A.E. A third Wilm's tumor locus on chromosome 16q. Cancer Res., 52: 3094-3098, 1992.
40. Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S.H., Masiarz, F.R., Munemitsu, S., and Polakis, P. Association of the APC gene product with β-catenin. Science (Washington DC), 262: 1731-1734, 1993.
41. Su, L.K., Vogelstein, B., and Kinzler, K.W. Association of the APC tumor suppressor protein with catenins. Science (Washington DC), 262: 1734-1737, 1993.
42. Mahoney, P.A., Weber, U., Onofrechuk, P., Biessmann, H., Bryant, P.J., and Goodman, C.S. The fat tumor suppressor gene in Drosophila encodes a novel member of the cadherin gene superfamily. Cell, 67: 853-68, 1991.
43. Fearon, E.R., Cho, K.R., Nigra, J.M., Kern, S.E., Simons, J.W., Ruppert, J.M., Hamilton, S.R., Preisinger, A.C., Thomas, G., Kinzler, K.W., and Vogelstein, B. Identification of an chromosome 18q gene that is altered in colorectal cancers. Science (Washington DC), 247: 49-56, 1990.
44. Uchino, S., Tsuda, H., Noguchi, M., Yokota, J., Terada, M., Saito, T., Koboyashi, M., Sugimura, T., and Hirohashi, S. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res., 52: 3099-3102, 1992.
45. Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.M., Orcutt, M.L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science (Washington DC), 260: 1317-1320, 1993.
46. Tsukita, S., Itoh, M., Nagafuchi, A., Yonemura, S., and Tsukita, S. Submembranous junctional plaque proteins include potential tumor suppressor molecules. J Cell Biol., 123: 1049-1053, 1993.